Clinical Trial Update: Effect of Percutaneous Botulinum Toxin A Injection on Natural Course of Upper Lid Retraction in Thyroid Eye Disease [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial is evaluating percutaneous botulinum toxin A injection to address upper lid retraction in thyroid eye disease. The sponsor is Shahid …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thyroid Eye Disease

Drugs mentioned

• Botulinum toxin A (botulinum toxin type A)

Snippet

Sponsor: Shahid Beheshti University of Medical Sciences | Conditions: Eye Diseases | Phase 2, Phase 3 | Status: UNKNOWN